Skip to main
SNYR

SNYR Stock Forecast & Price Target

SNYR Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Synergy CHC is facing short-term challenges due to weak Q1 results and the cancellation of a distribution deal in the Middle East, but the long-term potential for growth remains strong. With the FOCUSfactor brand showing significant growth and the company's strong position in the large brain health and energy RTD industries, there are multiple catalysts for potential growth. Despite current challenges, the company's recent long-term financial performance has been solid, and its undervalued stock presents a potential investment opportunity for those willing to bear the risks and uncertainties.

Bears say

Synergy CHC is facing significant financial challenges, as evidenced by its declining revenue and negative earnings in its latest quarter. With a substantial amount of debt and limited cash reserves, the company's financial position is precarious. Despite an attractive valuation, the risks associated with the company could outweigh the potential upside. The lack of Q4 guidance and weak Q1 results further demonstrate the uncertainties surrounding the company, and the lack of visibility on its future performance. Overall, there are concerns about the company's ability to turn around its financials and drive positive growth, making it a risky investment choice at this time.

SNYR has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Synergy CHC Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Synergy CHC Corp (SNYR) Forecast

Analysts have given SNYR a Strong Buy based on their latest research and market trends.

According to 2 analysts, SNYR has a Strong Buy consensus rating as of Aug 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $5.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $5.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Synergy CHC Corp (SNYR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.